Namibia commits to WHO’s Investment RoundNamibia contributed US$ 500 000 towards WHO’s Investment Round. Dr Kalumbi Shangula, Minister of Health and Social Services of Namibia announced the commitment: “It is critically important for WHO, which is a Member State driven organization, to be able to ...
Senegal commits to WHO’s Investment RoundSenegal contributed US$ 500 000 towards WHO's Investment Round. Dr Ibrahima Sy, Minister of Health and Social Action of Senegal announced the commitment: “Africa must mobilize in support of health because today we bear the heavy burden of emerging health ...
Launch of the Dashboard of Global Experiences on Refugee and Migrant HealthOver 1 billion people are on the move globally due to conflict, climate change, and other crises, seeking better lives. Despite the challenges in providing equitable healthcare, countries are making progress in meeting the health needs of refugees and migrants. This ...
Explore the WHO Health and Migration dashboard to enhance your knowledgeOver 1 billion people are on the move globally due to conflict, climate change, and other crises, seeking better lives. Despite the challenges in providing equitable healthcare, countries are making progress in meeting the health needs of refugees and migrants. This ...
CPRD Safe - The airlockHow the airlock, import and export requests, work when using the trusted research environment developed by the Clinical Practice Research Datalink (CPRD), named CPRD Safe, and how researchers may plan their projects. To find more information: https://www.cprd.com/safe
CPRD Safe - The pricing modelHow the pricing model and licence options work when using the trusted research environment developed by the Clinical Practice Research Datalink (CPRD), named CPRD Safe, and how researchers may plan the costs for their projects. To find more information: https://www.cprd.com/safe...
Introducing CPRD SafeAn introduction to the trusted research environment developed by the Clinical Practice Research Datalink (CPRD), named CPRD Safe, and how it enables secure access to data for public health research. To find more information: https://www.cprd.com/safe
Mpox (monkeypox)Mpox (monkeypox) elombatd@who.int Tue, 20/08/2024 - 09:08 Read more about Mpox (monkeypox) Mpox (monkeypox) is an infectious disease caused by the monkeypox virus. It can cause a painful rash, enlarged lymph nodes ...
Long COVID BasicsLearn about the potential COVID-19 long-term effects, including fatigue, shortness of breath, brain fog, chest pain, headache, and other symptoms.
Living with Long COVIDPeople with post-COVID conditions and those who support them can find ways to help, ways to cope with stress, and additional resources and support groups.
Weekly bulletinWeekly bulletin elombatd@who.int Fri, 10/05/2024 - 19:18 Read more about Weekly bulletin The Weekly Bulletin focuses on public health emergencies occurring in the WHO African Region. Each week, a brief description, followed ...
COVID-19 Testing: What You Need to KnowLearn about testing for COVID-19, including the types of tests, who should get tested, how to get tested, and print resources in English and Spanish.
DengueDengue elombatd@who.int Sat, 20/01/2024 - 18:12 Read more about Dengue Dengue fever is an arbovirus transmitted by Aedes mosquitoes (both Ae. aegypti and Ae. albopiticus). It is a severe, flu-like illness that affects infants, young children and adults, ...
Medicines and Healthcare products Regulatory Agency - Activity on GOV.UK
